NCT07901634
Association of Inflammatory Biomarkers and Ferritin With Severity of Pediatric Systemic Lupus Erythematosus Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Pediatric SLE Disease Severity Category
Timeframe: Baseline (at the time of evaluation / sample collection)
Secondary (5)
Systemic Immune-Inflammation Index (SII)
Serum Ferritin Level
Neutrophil-to-Lymphocyte Ratio (NLR)
Platelet-to-Lymphocyte Ratio (PLR)
Numerical SLEDAI-2K Score
Arms and interventions
Pediatric SLE Cohort
Pediatric patients diagnosed with systemic lupus erythematosus (pSLE). All participants undergo clinical and laboratory assessments, including complete blood counts to determine SII, NLR, and PLR, as well as serum ferritin levels. Disease severity is assessed and categorized into mild, moderate, or severe based on the SLEDAI-2K score